The effect of Curcumin on autism spectrum disorder

Evaluating the effect of adding Curcumin to Risperidone regimen on symptoms of autism spectrum disorder in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190915044774N1

Enrollment

Registered

2020-04-11

Start date

2019-12-11

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorders. Autism Spectrum Disorders

Interventions

Intervention 1: Intervention group: 120 mg tablet of curcumin orally administered divided into three doses daily for 6 weeks. The tablet is made by the Faculty of Pharmacy of Mashhad University of M

Eligibility

Sex/Gender

All

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Children with Autism spectrum disorder Age between 3 to 12 Under Risperidone treatment for at least 1 month

Exclusion criteria

Exclusion criteria: Other medical or congenital disease Intellectual disability:moderate or severe Without documented consent of the parents

Design outcomes

Primary

Measure	Time frame
Score in childhood autism rating scale questionnaire (CARS). Timepoint: Time 0, 3 weeks and 6 weeks after treatment. Method of measurement: Childhood Autism Rating Scale.;Score in clinical global improvement questionnaire (CGI). Timepoint: Time 0, 3 weeks and 6 weeks after treatment. Method of measurement: Clinical global improvement score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirfaraz Rezayeezadeh

Mashhad University of Medical Sciences

rezaeizadehaf951@mums.ac.ir+98 51 3842 5994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026